A key part of Biden’s plan to combat Covid is at risk as FDA meets to debate booster shots

A key FDA panel meets Friday to debate and vote at around 2:30 p.m. ET on Pfizer and BioNTech’s application to offer booster shots to the general public.

Health, Fitness & Food

Products You May Like

Articles You May Like

Colin Powell was vaccinated against Covid, but suffered from a cancer that makes the shots less effective
How BioNTech went from a little-known biotech company to creating the Covid vaccine
FDA clears Moderna and J&J Covid vaccine boosters, allows ‘mix and match’ shots
How rising UK Covid cases could be ‘a compelling argument for boosters’
‘The UK really is in trouble’: Doctors warn of a dire Covid crisis as officials reject restrictions

Leave a Reply

Your email address will not be published. Required fields are marked *